greeksoup/ stock research

Clorox (CLX) FY2025 results: revenue $7.1 billion, up 0.2% on the year

Clorox Co. (CLX) reported revenue of $7.1 billion for fiscal 2025, the year ended 30 June 2025, up 0.2% on the year before. Net income was $810 million, up 189.3%, and diluted earnings per share $6.52. The figures are the company's own, from the 10-K it filed with the SEC on 8 August 2025.

Revenue
$7.1 billion
+0.2% on the year
FY2018FY2025
Operating margin
n/a
FY2018FY2025
Net income
$810 million
+189.3% on the year
FY2018FY2025
Diluted EPS
$6.52
+189.8% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue7,1047,0937,389+0.2%
Cost of revenue3,8914,0454,481-3.8%
Gross profit3,2133,0482,908+5.4%
Gross margin45.2%43.0%39.4%
Research and development121126138-4.0%
Selling, general and administrative1,1241,1671,183-3.7%
Interest expense88.090.090.0-2.2%
Pre-tax income1,078398238+170.9%
Income tax25410677.0+139.6%
Effective tax rate23.6%26.6%32.4%
Net income810280149+189.3%
Net margin11.4%3.9%2.0%
Diluted EPS$6.52$2.25$1.20+189.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow9816951,158+41.2%
Capital expenditure220212228+3.8%
Free cash flow761483930+57.6%
Free cash flow margin10.7%6.8%12.6%
Cash from investing-94.0-175-223
Cash from financing-924-655-753
Depreciation and amortisation219235236-6.8%
Share-based compensation81.074.073.0+9.5%
Buybacks3320.00.0
Dividends paid602595583+1.2%
Dividend per share$4.88$4.80$4.72+1.7%
Diluted shares, weighted124m125m124m-0.4%
Shares outstanding at period end123m124m124m-1.2%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity321328220-2.1%
Non-controlling interest161164168-1.8%
Debt2,4842,4812,527+0.1%
Operating lease liabilities305334310-8.7%
Finance lease liabilities21.021.021.00.0%
Other liabilities2,2692,4232,699-6.4%
Total liabilities and equity5,5615,7515,945-3.3%
Fixed assets1,2671,3151,345-3.7%
Goodwill1,2291,2281,252+0.1%
Intangible assets566681712-16.9%
Cash and equivalents167202367-17.3%
Receivables821695688+18.1%
Inventory523637696-17.9%
Other assets988993885-0.5%
Total assets5,5615,7515,945-3.3%

10-K for the year ended 30 June 2025, filed 8 August 2025: the filing.